Imai, H.; Onozato, R.; Ginnan, M.; Kobayashi, D.; Kaira, K.; Minato, K.
Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations. Medicina 2021, 57, 508.
https://doi.org/10.3390/medicina57050508
AMA Style
Imai H, Onozato R, Ginnan M, Kobayashi D, Kaira K, Minato K.
Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations. Medicina. 2021; 57(5):508.
https://doi.org/10.3390/medicina57050508
Chicago/Turabian Style
Imai, Hisao, Ryoichi Onozato, Maiko Ginnan, Daijiro Kobayashi, Kyoichi Kaira, and Koichi Minato.
2021. "Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations" Medicina 57, no. 5: 508.
https://doi.org/10.3390/medicina57050508
APA Style
Imai, H., Onozato, R., Ginnan, M., Kobayashi, D., Kaira, K., & Minato, K.
(2021). Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations. Medicina, 57(5), 508.
https://doi.org/10.3390/medicina57050508
